We further found that IL22RA1, one of the IL-22 receptor subunits, was aberrantly overexpressed in CTCL, and that its knockdown decreased CCL20 production [21]. This evidence concerns the gene CCL20 and primary cutaneous T-cell non-Hodgkin lymphoma.